Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: Germany Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20053
20064
20071
20083
20095
20107
20114
20126
20136
20143
20155
20163
20174
20188
20198
20202
20214
20224

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer13
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest5
Bristol-Myers Squibb4
Eli Lilly and Company4
University Hospital Freiburg4
Boston Scientific Corporation3
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
BeiGene2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular83
Liver Neoplasms16
Neoplasms5
Carcinoma3
Carcinoma, Non-Small-Cell Lung3
Carcinoma, Renal Cell3
Cholangiocarcinoma3
Hepatitis C3
Liver Cirrhosis3
Liver Diseases3

Trials

Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.